ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,202Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 97

$619K Total Retail Price of All Prescriptions

Rank: 21 out of 97

510 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 9,941 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 511 476 1 2
FUROSEMIDE 469 427 2 3
LEVOTHYROXINE SODIUM 426 410 3 1
LISINOPRIL 355 324 4 4
METOPROLOL TARTRATE 342 332 5 7
HYDROCHLOROTHIAZIDE 334 311 6 9
METOPROLOL SUCCINATE 307 273 7 8
METFORMIN HCL 306 270 8 12
ATORVASTATIN CALCIUM 269 222 9 14
AMLODIPINE BESYLATE 262 254 10 6
SERTRALINE HCL 253 211 11 16
LOSARTAN-HYDROCHLOROTHIAZIDE 198 180 12 49
ENALAPRIL MALEATE 194 184 13 47
GLIMEPIRIDE 189 178 14 39
ALLOPURINOL 185 179 15 22
WARFARIN SODIUM 185 181 15 11
POTASSIUM CHLORIDE 180 160 17 10
CRESTOR 179 178 18 29
ISOSORBIDE MONONITRATE ER 178 165 19 27
LOSARTAN POTASSIUM 176 157 20 13
OMEPRAZOLE 168 138 21 5
ATENOLOL 162 150 22 15
CARVEDILOL 152 144 23 25
DIGOXIN 150 150 24 26
TAMSULOSIN HCL 110 99 25 31
SPIRONOLACTONE 105 93 26 33
LANTUS 102 72 27 43
GABAPENTIN 101 87 28 18
ADVAIR DISKUS 95 72 29 40
TRAZODONE HCL 93 69 30 42
LANTUS SOLOSTAR 90 68 31 41
MOEXIPRIL-HYDROCHLOROTHIAZIDE 81 80 10 32 183
NOVOLOG FLEXPEN 78 57 33 74
ENALAPRIL-HYDROCHLOROTHIAZIDE 77 77 34 185
RAMIPRIL 76 71 35 68
DILTIAZEM ER 75 65 36 85
BUSPIRONE HCL 73 61 37 107
PREDNISONE 71 65 38 23
FLUTICASONE PROPIONATE 69 67 39 52
SPIRIVA 66 58 40 48
NAMENDA 66 66 40 38
DOXYCYCLINE HYCLATE 65 63 42 164
TRAMADOL HCL 63 56 43 21
PAROXETINE HCL 62 59 44 56
INSULIN SYRINGE 62 51 44 88
CLONIDINE HCL 60 51 46 72
CLOPIDOGREL 57 42 47 34
CITALOPRAM HBR 57 48 47 20
NOVOLOG 55 44 49 123
LEVEMIR FLEXPEN 54 46 50 133
PLAVIX 53 38 51 46
HYDRALAZINE HCL 50 50 52 84
JANTOVEN 50 50 52 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.